Evecxia Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Evecxia Therapeutics General Information
Description
Operator of a biotechnology platform intended to develop therapies for neuropsychiatric disorders through serotonin amplification. The company offers oral tablet technology that supports sustained plasma levels of 5-HTP and prolonged brain serotonin synthesis, enabling physicians and healthcare providers to treat neuropsychiatric conditions with scalable antidepressant augmentation pharmacology.
Contact Information
Website
www.evecxia.comCorporate Office
- First Flight Venture Center, 2 Davis Drive
- PO Box 13169, Research Triangle Park
- Durham, NC 27709
- United States
Corporate Office
- First Flight Venture Center, 2 Davis Drive
- PO Box 13169, Research Triangle Park
- Durham, NC 27709
- United States
Evecxia Therapeutics Timeline
Evecxia Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 5. Later Stage VC | 16-Sep-2025 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC | 01-Feb-2025 | Completed | Clinical Trials - Phase 1 | |||
| 3. Later Stage VC | 20-Aug-2022 | Completed | Clinical Trials - Phase 1 | |||
| 2. Later Stage VC | 09-Nov-2020 | $8.5M | $9M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 01-Jan-2016 | $500K | $500K | Completed | Clinical Trials - Phase 1 |
Evecxia Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Evecxia Therapeutics Comparisons
Industry
Financing
Details
Evecxia Therapeutics Competitors (9)
One of Evecxia Therapeutics’s 9 competitors is AtaiBeckley, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AtaiBeckley | Formerly VC-backed | New York, NY | ||||
| Autobahn Therapeutics | Venture Capital-Backed | San Diego, CA | ||||
| Neurocrine Biosciences | Formerly VC-backed | San Diego, CA | ||||
| Definium Therapeutics | Formerly VC-backed | New York, NY | ||||
| Xenon Pharmaceuticals | Formerly VC-backed | Burnaby, Canada |
Evecxia Therapeutics Patents
Evecxia Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024148354-A1 | A method of enhancing 5-hydroxytryptophan (5-htp) exposure | Inactive | 06-Jan-2023 | ||
| EP-4392031-A1 | A method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes | Pending | 14-Oct-2021 | ||
| EP-4392031-A4 | A method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes | Pending | 14-Oct-2021 | ||
| WO-2023064598-A1 | A method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes | Inactive | 14-Oct-2021 | ||
| US-11779567-B2 | Method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes | Active | 14-Oct-2021 | A61K31/405 |
Evecxia Therapeutics Signals
Evecxia Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Collage Venture Partners | Venture Capital | Minority | ||
| Bull City Venture Partners | Venture Capital | Minority |
Evecxia Therapeutics FAQs
-
When was Evecxia Therapeutics founded?
Evecxia Therapeutics was founded in 2013.
-
Where is Evecxia Therapeutics headquartered?
Evecxia Therapeutics is headquartered in Durham, NC.
-
What is the size of Evecxia Therapeutics?
Evecxia Therapeutics has 2 total employees.
-
What industry is Evecxia Therapeutics in?
Evecxia Therapeutics’s primary industry is Drug Discovery.
-
Is Evecxia Therapeutics a private or public company?
Evecxia Therapeutics is a Private company.
-
What is Evecxia Therapeutics’s current revenue?
The current revenue for Evecxia Therapeutics is .
-
How much funding has Evecxia Therapeutics raised over time?
Evecxia Therapeutics has raised $32M.
-
Who are Evecxia Therapeutics’s investors?
Collage Venture Partners and Bull City Venture Partners have invested in Evecxia Therapeutics.
-
Who are Evecxia Therapeutics’s competitors?
AtaiBeckley, Autobahn Therapeutics, Neurocrine Biosciences, Definium Therapeutics, and Xenon Pharmaceuticals are some of the 9 competitors of Evecxia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process